COMMUNIQUÉS West-GlobeNewswire

CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
29/07/2026
PARSIPPANY, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the second quarter ended June 30, 2026, before the market opens on [...]
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
29/07/2026
PDUFA target action date of November 28, 2026, approximately one quarter ahead of Company’s previously communicated guidance FDA identified no Filing review issues Acceptance triggers $15 million milestone payment, [...]
TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages
29/07/2026
-Carbonium Merger Remains on Track -European Regulatory Expansion and Partnership Growth -Advancement of Biosafety Cabinet Standards -Defense Sector Growth FREDERICK, Md., July 29, 2026 (GLOBE NEWSWIRE) -- TOMI [...]
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
29/07/2026
WEST PALM BEACH, FL, July 29, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc.’s (OTC: FOXOD/FOXO) ( “FOXO”) subsidiary, Vector BioSource, Inc. (“Vector”) today announced that it has entered into a definitive agreement [...]
Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France
29/07/2026
July 28, 2026 Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products [...]
Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
29/07/2026
DURHAM, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for [...]
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma
29/07/2026
FDA Granted RMAT Designation Based on ALPHA3 Trial Futility Analysis, Highlighting Cema-Cel’s Potential to Transform Disease Treatment in First-Line LBCL Consolidation Cema-Cel Induced Rapid and Substantial MRD [...]
ACTG to Make Three Presentations on HIV Cure and Aging with HIV at AIDS 2026
29/07/2026
CHAPEL HILL, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced today that it will make three presentations at AIDS 2026 , which is [...]
Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston
29/07/2026
NEEDHAM, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve [...]
NewAmsterdam Pharma to Host Investor Day on August 5, 2026
29/07/2026
NAARDEN, The Netherlands and MIAMI, July 29, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026
29/07/2026
Conference Call and Webcast Scheduled for Wednesday, August 5th, 2026, at 10:00 AM ET PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and [...]
Noom Health partners with Levrx to bring personalized weight management support into the pharmacy benefits experience
29/07/2026
PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Noom Health, the enterprise arm of Noom and a leading behavior change platform, today announced a new integration with Levrx Technology, a pharmacy navigation and [...]
Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights
29/07/2026
Akebia to Host Conference Call on August 5 at 4:30 p.m. EDT CAMBRIDGE, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the [...]
Jushi Holdings Provides Update on Plan of Arrangement
29/07/2026
BOCA RATON, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“ Jushi ” or the “ Company ”) ( CSE: JUSH ) ( OTCQX: JUSHF ) , a vertically integrated, multi-state cannabis operator, announces that, further to [...]
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
29/07/2026
AUSTIN, Texas, July 29, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing therapies for Tuberous Sclerosis [...]
Realize Medical Appoints Chris Marrus to Board of Directors
29/07/2026
Surgical robotics and medtech commercialization veteran joins Realize Medical's board as the company scales Elucis, its FDA-cleared VR surgical planning platform OTTAWA, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- [...]
PROLLENIUM® Expands PACE with Launch of Eight New Clinical Education Modules
29/07/2026
New modules, developed with Harley Academy, extend the PACE Training & Education Portal across foundational and advanced clinical techniques RICHMOND HILL, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- PROLLENIUM® , a [...]
MediWound to Report Second Quarter 2026 Financial Results
29/07/2026
MediWound to Report Second Quarter 2026 Financial Results Conference Call and Webcast Scheduled for Thursday, August 13 at 8:30 a.m. Eastern Time YAVNE, Israel, July 29, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global [...]
LB Pharmaceuticals Announces $150 Million Private Placement
29/07/2026
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]

Pages